Adipose Stroma Accelerates the Invasion and Escape of Human Breast Cancer Cells from an Engineered Microtumor.

TitleAdipose Stroma Accelerates the Invasion and Escape of Human Breast Cancer Cells from an Engineered Microtumor.
Publication TypeJournal Article
Year of Publication2022
AuthorsDance, YW, Meshulam, T, Seibel, AJ, Obenreder, MC, Layne, MD, Nelson, CM, Tien, J
JournalCell Mol Bioeng
Volume15
Issue1
Pagination15-29
Date Published2022 Feb
ISSN1865-5025
Abstract

<p><b>INTRODUCTION: </b>Approximately 20-25% of human breast tumors are found within an adipose, rather than fibrous, stroma. Adipose stroma is associated with an increased risk of lymph node metastasis, but the causal association between adipose stroma and metastatic progression in human breast cancer remains unclear.</p><p><b>METHODS: </b>We used micropatterned type I collagen gels to engineer ~3-mm-long microscale human breast tumors within a stroma that contains adipocytes and adipose-derived stem cells (ASCs) (collectively, "adipose cells"). Invasion and escape of human breast cancer cells into an empty 120-μm-diameter lymphatic-like cavity was used to model interstitial invasion and vascular escape in the presence of adipose cell-derived factors for up to 16 days.</p><p><b>RESULTS: </b>We found that adipose cells hasten invasion and escape by 1-2 days and 2-3 days, respectively. These effects were mediated by soluble factors secreted by the adipose cells, and these factors acted directly on tumor cells. Surprisingly, tumor invasion and escape were more strongly induced by ASCs than by adipocytes.</p><p><b>CONCLUSIONS: </b>This work reveals that both adipocytes and ASCs accelerate the interstitial invasion and escape of human breast cancer cells, and sheds light on the link between adipose stroma and lymphatic metastasis in human breast cancer.</p><p><b>SUPPLEMENTARY INFORMATION: </b>The online version contains supplementary material available at 10.1007/s12195-021-00697-6.</p>

DOI10.1007/s12195-021-00697-6
Alternate JournalCell Mol Bioeng
PubMed ID35096184
PubMed Central IDPMC8761189